In addition, decorin expression seems to follow the BCLC (Barcelona Clinic Liver Cancer) staging classification as significantly decreased decorin level was observed in every BCLC stage compared to normal liver (p < 0.001), and its level gradually decrease from BCLC 0 to BCLC B (p < 0.05 and 0.01; Figure 1D). Here, DCN is linked to liver cancer.